Avariant allele of growth factor independence 1 (GFI1) is associated with acute myeloid leukemia

Blood

Volumn 115, Issue 12, 2010, Pages 2462-2472

  Khandanpour, Cyrus ^a,b   Thiede, Christian ^c   Valk, Peter J M ^d   Sharif Askari, Ehssan ^a   Nückel, Holger ^b   Lohmann, Dietmar ^b   Horsthemke, Bernhard ^b   Siffert, Winfried ^b   Neubauer, Andreas ^e   Grzeschik, Karl Heinz ^f   Bloomfield, Clara D ^g   Marcucci, Guido ^g   Maharry, Kati ^g,h   Slovak, Marilyn L ⁱ   Van Der Reijden, Bert A ^j   Jansen, Joop H ^j   Schackert, Hans K ^k   Afshar, Khashayar ^a   Schnittger, Susanne ^l   Peeters, Justine K ^d   Kroschinsky, Frank ^c   Ehninger, Gerhard ^c   Lowenberg, Bob ^d   Dührsen, Ulrich ^b   Möröy, Tarik ^a,b   more..

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e UNIVERSITY HOSPITAL MARBURG   (Germany)

^f PHILIPPS UNIVERSITY MARBURG   (Germany)

^g THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^h Statistical Center   (United States)

ⁱ CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^j RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^k DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^l MLL MUNICH LEUKEMIA LABORATORY   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX1T1; UNCLASSIFIED DRUG; AML1 ETO FUSION PROTEIN, HUMAN; AML1-ETO FUSION PROTEIN, HUMAN; DNA BINDING PROTEIN; GFI1 PROTEIN, HUMAN; ONCOPROTEIN; TRANSCRIPTION FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; BLOOD CELL COUNT; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GROWTH FACTOR INDEPENDENCE 1 GENE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; CELL NUCLEUS; CELL STRAIN 3T3; CELL STRAIN COS1; CERCOPITHECUS; GENE TRANSLOCATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; HELA CELL; METABOLISM; MIDDLE AGED; MOUSE;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CELL NUCLEUS; CERCOPITHECUS AETHIOPS; CORE BINDING FACTOR ALPHA 2 SUBUNIT; COS CELLS; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HELA CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; LINKAGE DISEQUILIBRIUM; MALE; MICE; MIDDLE AGED; NIH 3T3 CELLS; ONCOGENE PROTEINS, FUSION; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC; YOUNG ADULT;

EID: 77950582398     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-08-239822     Document Type: Article

References (47)

1. Estey E, Döhner H. Acute myeloid leukemia. Lancet. 2006;368(9550):1894-1907.
2. Löwenberg B, Downing JR, Burnett A. Acute myeloid leukemia. N Engl J Med. 1999;341(14): 1051-1062.
3. Steidl U, Rosenbauer F, Verhaak RG, et al. Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells. Nat Genet. 2006;38(11):1269-1277. (Pubitemid 44646289)
4. Steidl U, Steidl C, Ebralidze A, et al. A distal single nucleotide polymorphism alters long-range regulation of the PU.1 gene in acute myeloid leukemia. J Clin Invest. 2007;117(9):2611-2620. (Pubitemid 47494362)
5. Kirstetter P, Schuster MB, Bereshchenko O, et al. Modeling of C/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells. Cancer Cell. 2008;13(4):299-310. (Pubitemid 351446194)
6. Paschka P, Marcucci G, Ruppert AS, et al. Cancer and Leukemia Group B. Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study. J Clin Oncol. 2006; 24(24):3904-3911. (Pubitemid 46630738)
7. Schlenk RF, Döhner K, Krauter J, et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med. 2008; 358(18):1909-1918. (Pubitemid 351620111)
8. Karsunky H, Zeng H, Schmidt T, et al. Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1. Nat Genet. 2002;30(3):295-300.
9. Hock H, Hamblen MJ, Rooke HM, et al. Intrinsic requirement for zinc finger transcription factor Gfi-1 in neutrophil differentiation. Immunity. 2003; 18(1):109-120. (Pubitemid 36120692)
10. Hock H, Orkin SH. Zinc-finger transcription factor Gfi-1: versatile regulator of lymphocytes, neutrophils and haematopoietic stem cells Curr Opin Hematol. 2006;13(1):1-6. (Pubitemid 43755839)
11. Kazanjian A, Gross EA, Grimes HL. The growth factor independence-1 transcription factor: new functions and new insights. Crit Rev Oncol Hematol. 2006;59(2):85-97. (Pubitemid 44094109)
12. Zörnig M, Schmidt T, Karsunky H, Grzeschiczek A, Möröy T. Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2. Oncogene. 1996;12(8):1789-1801 (Pubitemid 26146304)
13. Gilks CB, Bear SE, Grimes HL, Tsichlis PN. Progression of interleukin-2 (IL-2)-dependent rat T-cell lymphoma lines to IL-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein. Mol Cell Biol. 1993; 13(3):1759-1768.
14. Yücel R, Kosan C, Heyd F, Möröy T. Gfi1:green fluorescent protein knock-in mutant reveals differential expression and autoregulation of the growth factor independence 1 (Gfi1) gene during lymphocyte development. J Biol Chem. 2004; 279(39):40906-40917. (Pubitemid 39287690)
15. Rathinam C, Lassmann H, Mengel M, Klein C. Transcription factor Gfi1 restricts B-cell-mediated autoimmunity. J Immunol. 2008;181(9):6222-6229.
16. Zhu J, Jankovic D, Grinberg A, Guo L, Paul WE. Gfi-1 plays an important role in IL-2-mediated Th2 cell expansion. Proc Natl Acad Sci U S A. 2006;103(48):18214-18219. (Pubitemid 44871638)
17. Heyd F, ten Dam G, Möröy T. Auxiliary splice factor U2AF26 and transcription factor Gfi1 cooperate directly in regulating CD45 alternative splicing. Nat Immunol. 2006;7(8):859-867. (Pubitemid 44084093)
18. Rathinam C, Geffers R, Yücel R, et al. The transcriptional repressor Gfi1 controls STAT3-dependent dendritic cell development and function. Immunity. 2005;22(6):717-728. (Pubitemid 40814502)
19. Fiolka K, Hertzano R, Vassen L, et al. Gfi1 and Gfi1b act equivalently in haematopoiesis, but have distinct, on-overlapping functions in inner ear development. EMBO Rep. 2006;7(3):326-333.
20. Tsuda H, Jafar-Nejad H, Patel AJ, et al. The AXH domain of Ataxin-1 mediates Neuro-degeneration through its interaction with Gfi-1/Senseless proteins. Cell. (2005);122(4):633-644. (Pubitemid 41191160)
21. Hock H, Hamblen MJ, Rooke HM, et al. Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells. Nature. 2004(7011):431:1002-1007. (Pubitemid 39434423)
22. Zeng H, Yücel R, Kosan C, Klein-Hitpass L, Möröy T. Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells. EMBO J. 2004;23(20):4116-4125. (Pubitemid 39472432)
23. Person RE, Li FQ, Duan Z, Benson KF, et al. Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat Genet. 2003; 34(3):308-312. (Pubitemid 36792864)
24. Valk PJ, Verhaak RG, Beijen MA, et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med. 2004;350(16): 1617-1628. (Pubitemid 38528701)
25. Stein AS, O'Donnell MR, Slovak ML, et al. Interleukin-2 after autologous stem-cell transplantation for adult patients with acute myeloid leukemia in first complete remission. J Clin Oncol. 2003;21(4):615-623. (Pubitemid 46621894)
26. Schaich M, Ritter M, Illmer T, et al. Mutations in RAS proto-oncogenes are associated with lower mdr1 gene expression in adult acute myeloid leukaemia Br J Haematol. 2001;112(2):300-307. (Pubitemid 32183470)
27. Kasim K, Levallois P, Abdous B, Auger P, Johnson KC. Lifestyle factors and the risk of adult leukemia in Canada. Cancer Causes Control. 2005;16(5):489-500. (Pubitemid 40933619)
28. Sandler DP, Shore DL, Anderson JR, et al. Cigarette smoking and risk of acute leukemia: associations with morphology and cytogenetic abnormalities in bone marrow. J Natl Cancer Inst. 1993;85(24):1994-2003.
29. Sasieni PD. From genotypes to genes: doubling the sample size. Biometrics. 1997;53(4):1253-1261.
30. McGhee L, Bryan J, Elliott L, et al. Gfi-1 attaches to the nuclear matrix, associates with ETO (MTG8) and histone deacetylase proteins, and represses transcription using a TSA-sensitive mechanism. J Cell Biochem. 2003;89(5):1005-1018. (Pubitemid 36927731)
31. Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F, Bertil EG. Wintrobe's Clinical Hematology. 11th ed. Philadelphia, PA: Lippincott, Williams and Wilkins; 2004:2098-2099.
32. The International HapMap Consortium. The International HapMap Project. Nature. 2003; 426(6968):789-796.
33. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science. 2002(5576):296:2225-2229. (Pubitemid 34680308)
34. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308(5720):385-389. (Pubitemid 40530070)
35. Rödel B, Tavassoli K, Karsunky H, et al. The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3. EMBO J. 2000;19(21):5845-5855.
36. Doan LL, Porter SD, Duan Z, et al. Targeted transcriptional repression of GFI1 by GFI1 and GFI1B in lymphoid cells. Nucleic Acids Res. 2004;32(8): 2508-2519. (Pubitemid 38854803)
37. Rhoades KL, Hetherington CJ, Rowley JD, et al. Synergistic up-regulation of the myeloid specific promoter for the macrophage colony stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis. Proc Natl Acad Sci U S A. 1996;93(21):11895-11900.
38. Yang G, Khalaf W, van de Locht L, et al. Transcriptional repression of the Neurofibromatosis-1 tumor suppressor by the t(8;21) fusion protein. Mol Cell Biol. 2005;25(14):5869-5879. (Pubitemid 40946544)
39. Vangala RK, Heiss-Neumann MS, Rangatia JS, et al. The myeloid master regulator transcription factor PU1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia. Blood. 2003;101(1):270-277.
40. McNeil S, Zeng C, Harrington KS, et al. The t(8;21) chromosomal translocation in acute myelogenous leukemia modifies intranuclear targeting of the AML1/CBFalpha2 transcription factor. Proc Natl Acad Sci U S A. 1999;96(26):14882-14887. (Pubitemid 30019734)
41. Yuan Y, Zhou L, Miyamoto T, et al. AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations. Proc Natl Acad Sci U S A. 2001;98(18):10398-10403 (Pubitemid 32803031)
42. Higuchi M, O'Brien D, Kumaravelu P, Lenny N, Yeoh EJ, Downing JR. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. Cancer Cell. 2002;1(1):63-74. (Pubitemid 41039177)
43. Hochberg JC, Miron PN, Hay BN, et al. Mosaic tertraploidy and transient GFI1 mutation in a patient with severe chronic neutropenia. Pediatric Blood Cancer. 2008;50(3):630-632.
44. Zaidi SK, Javed A, Pratap J, et al. Alterations in Intranuclear Localization of Runx 2 affect biological activity. J Cell Physiol. 2006;209(3):935-994 (Pubitemid 44665715)
45. Duan Z, Zarebski A, Montoya-Durango D, Grimes HL, Horwitz M. Gfi1 coordinates epigenetic repression of p21Cip/WAF1 by recruitment of histone lysinemethyltransferase G9a and histone deacetylase 1. Mol Cell Biol. 2005;25(23):10338-10351. (Pubitemid 41681959)
46. Saleque S, Kim J, Rooke H, Orkin SH. Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1. Mol Cell. 2007;27(4):562-572. (Pubitemid 47238633)
47. Horman SR, Velu CS, Chaubey A, et al. Gfi1 integrates progenitor versus granulocytic transcriptional programming. Blood. 2009;113(22):5466-5475.